Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype

References

• Allison ME, Wreghitt T, Palmer CR, Alexander GJM. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135–1139.
   PubMed Web of Science ®Google Scholar
• Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000;133:592–599.
   PubMed Web of Science ®Google Scholar
• Grimbert S, Valensi P, Levy-Marchal C, Perret G, Richardet JP, Raffloux C, Thinchet JC, Beaugrand M. High prevalence of diabetes mellitus in patients with chronic hepatitis C: a case-control study. Gastroenterol Clin Biol 1996;20:544–548.
   PubMedGoogle Scholar
• Knobler H, Schihmanter R, Zifroni A, Fenakel G, Strathdee AS. A increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000;75:355–359.
   PubMed Web of Science ®Google Scholar
• Warran JH, Martin BC, Krolewski AS, Soeldner JS, Kann CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents Ann Intern Med 1990;113:909–915.
   Google Scholar
• Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kann CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus; results of 25-year follow-up study. Lancet 1992;340:920–929.
   Google Scholar
• Cua IH, Hui JM, Kench JG, George J. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. Hepatology 2008;48:723–731.
   PubMed Web of Science ®Google Scholar
• El-Zayadi AR. Hepatic steatosis: a benign disease or a silent killer. World J Gastroenterol 2008;14:4120–4126.
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol 2003;98:2064–2071.
   PubMed Web of Science ®Google Scholar
• Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, Younossi Z, Albrecht J. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 2003;38:75–85.
   PubMed Web of Science ®Google Scholar
• Hui JM, Sud A, Farrel GC, Bandara P, Byth K, Kench JG, McCaughan GW, Goerge J. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003;125:1695–1704.
   PubMed Web of Science ®Google Scholar
• Muzzi A, Leandro G, Rubbia-Brandt L, James R, Keiser O, Mallinverni R, Dufour JF, Helbling B, Hadengue A, Gonvers JJ, Mullhaupt B, Cerny A, Mondelli MU, Negro F. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C. J Hepatol 2005;42:41–46.
   PubMed Web of Science ®Google Scholar
• D'Souza R, Sabin CA, Foster GR. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol 2005;100:1509–1515.
   PubMed Web of Science ®Google Scholar
• Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Sem Liver Dis 2001;21:27–41.
   PubMed Web of Science ®Google Scholar
• De Maria N, Colantoni A, Fagiuoli S, Liu G-J, Rogers BK, Farinati F, Van Thiel DH, Floyd RA. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996;21:291–295.
   PubMed Web of Science ®Google Scholar
• Vendemiale G, Grattagliano I, Portincasa P, Serviddio G, Palasciamo G, Altomare E. Oxidative stress in symptom-free HCV carriers: relation with ALT flare-up. Eur J Clin Invest 2001;31:54–63.
   PubMedGoogle Scholar
• Jain SK, Pemberton PW, Smith A, McMahon RF, Burrows PC, Aboutwerat A, Warnes TW. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002;36:805–811.
   PubMed Web of Science ®Google Scholar
• Yadav D, Hertan HI, Schweitzer P, Norkus EP, Pitchumoni CS. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol 2002;97:2534–2539.
   Google Scholar
• Bedossa P, Poynard T An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289–293.
   PubMed Web of Science ®Google Scholar
• Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Sem Liv Dis 2001;21:3–16.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412–419.
   PubMed Web of Science ®Google Scholar
• Junqueira VBC, Barros SBM, Chan SS, Rodrigues L, Giavarotti L, Abud RL, Deucher GP. Aging and oxidative stress. Molec Aspects Med 2004;25:5–16.
   PubMedGoogle Scholar
• Buss H, Cahn TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive Elisa method. Free Radic Biol Med 1997;23:361–366.
   PubMed Web of Science ®Google Scholar
• Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502–522.
   PubMed Web of Science ®Google Scholar
• Gomes LF, Alves AF, Sevanian A, Peres CA, Cendoroglo MS, de Mello-Almada C, Quirino LM, Ramos LR, Junqueira VBC. Role of beta2-glycoprotein I, LDL-, and antioxidant levels in hypercholesterolemic elderly subjects. Antioxid Redox Signal 2004;6:237–244.
   Google Scholar
• Glantz AG. Primer of bio-statistic. 4th. New York: McGraw-Hill, Inc; 1992.
   Google Scholar
• Leonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extra-hepatic disease. Gastroenterology 2004;126:586–597.
   Google Scholar
• Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 2001;34:428–434.
   PubMed Web of Science ®Google Scholar
• Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D Antó M, Capasso R, Zappia V, Ruggiero G. Hiperhomocisteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C. Hepatology 2005;41:995–1003.
   PubMed Web of Science ®Google Scholar
• Charlton MR, Pockros PJ, Harrison AS. Impact of obesity on treatment of chronic hepatitis C. Hepatology 2006;43:1177–1186.
   PubMed Web of Science ®Google Scholar
• Hu K-Q, Kyulo L, Esrailian E, Thompson K, Chase R, Hillebrand DJ, Runyon BA. Overweight and obesity, hepatic steatosis and progression of chronic hepatitis C: a retrospective study of a large cohort of patients in the United States. J Hepatol 2004;40:147–154.
   PubMed Web of Science ®Google Scholar
• Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male PJ, Giostra E, Carlotti A, Bozzola L, Smedile A, Negro F. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut 2004;53:406–412.
   PubMed Web of Science ®Google Scholar
• Hourigan LK, Macdonald GA, Purdie D. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999;29:1215–1219.
   PubMed Web of Science ®Google Scholar
• Day CP, James OFW. Steatohepatitis: A tale of two ‘hits’? Gastroenterology 1998;114:842–845.
   PubMed Web of Science ®Google Scholar
• Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995;96:2461–2468.
   PubMed Web of Science ®Google Scholar
• Svegliati Baroni G, D'Ambrosio L, Ferretti G, Casini A, DiSario A, Salzano R, . Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998;27:720–726.
   PubMed Web of Science ®Google Scholar
• Kitase A, Hino K, Furutani T, Okuda M, Gondo T, Hidaka I, Hara Y, Yamaguchi Y, Okita K. In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis. J Gastroenterol 2005;40:617–624.
   Google Scholar
• Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001;35:297–306.
   PubMed Web of Science ®Google Scholar
• Bonnefont-Rousselot D, Ratziu V, Giral P, Charlotte F, Beucler I, Poynard T. Blood oxidative stress markers are unreliable markers of hepatic steatosis. Aliment Pharmacol Ther 2005;23:91–98.
   Google Scholar
• Mitsuyoshi H, Itoh Y, Sumida Y, Minami M, Yasui K, Nakashima T, Okanue T. Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C. Hepatol Res 2008;38:348–353.
   PubMed Web of Science ®Google Scholar
• Boya P, Pena ADL, Beloqui O, Larrea E, Conchillo M, Castelruiz Y, Civeira MP, Prieto J. Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C. J Hepatol 1999;31:808–814.
   PubMed Web of Science ®Google Scholar
• Levent G, Ali A, Ahmet A, Polat EC, Aytac ç, Ayse E, Ahmet S. Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J Transl Med 2006;4:25–
   PubMed Web of Science ®Google Scholar
• Kageyama F, Kobayashi Y, Kawasaki T, Toyokuni S, Uchida K, Nakamura H. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 2000;95:1041–1050.
   PubMed Web of Science ®Google Scholar
• Romero-Gomez M, Villoria MDM, Andrade RJ, Salmeron J, Diago M, Fernandez-Rodriguez CM, Corpas R, Cruz M, Grande L, Vazquez L, Munoz-De-Rueda P, Lopez-Serrano P, Gila A, Gutierrez ML, Perez C, Ruiz-Extremera A, Suarez E, Castillo J. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005;128:636–641.
   PubMed Web of Science ®Google Scholar
• Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, Miyamura T, Koike K. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997;78:1527–1531.
   PubMed Web of Science ®Google Scholar
• Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003;38:1384–1392.
   PubMed Web of Science ®Google Scholar
• Delgado-Borrego A, Liu YS, Jordan SH, Agrawal S, Zhang H, Cristofi M, Casson D, Cosimi B, Chung RT. Prospective study of liver transplant recipients with HCV infection: evidence for a casual relationship between HCV and insulin resistance. Liver Transpl 2008;14:193–201.
   Google Scholar
• Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lenon SM, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122:366–375.
   PubMed Web of Science ®Google Scholar
• Korenaga M, Wang T, Li Y, Showalter LA, Chan T, Sun J, Sun JR, Weinman SA. Hepatitis C virus core protein inhibit smitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 2005;280:37481–37488.
   PubMed Web of Science ®Google Scholar
• Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003;52:1–8.
   PubMed Web of Science ®Google Scholar
• Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Noclas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA levels and liver fibrosis. Gastroenterology 2008;134:416–423.
   PubMed Web of Science ®Google Scholar
• Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Hepatology 2006;44:1648–1655.
   PubMed Web of Science ®Google Scholar
• Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, Sutti S, Marrone A, Ruggiero G, Albano E, Adinolfi LE. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol 2008;48:399–406.
   PubMed Web of Science ®Google Scholar